1,290 articles
Gilead’s patent for Sofosbuvir was rejected by the Indian Patent Office on grounds of insufficient therapeutic efficacy. This landmark decision enables wider access to affordable generic Hepatitis C…
The Indian Patent Office has revoked Roche’s patent on Bonviva after Cipla challenged its validity, citing a lack of inventive step and patentability. This decision highlights critical aspects…
Weekly IP Warm-UP covers notable intellectual property law updates, including copyright and patent litigation, music industry developments, and trade secrets cases. The post analyses recent legal changes and…
The Indian Patent Office set aside Abbott Biotechnology's Humira patent after Glenmark's pre-grant opposition, citing lack of inventive step and insufficient disclosure. This legal dispute underscores ongoing challenges…
An article published in the Indian Express on 11/01/2015, titled “More Spends on Patents Needed”, examined the comparatively low number of patents filed by Indian companies relative to…
RPX Corp. is acquiring around 4,000 patents from Apple’s Rockstar Consortium for US$ 900 million, effectively ending several major patent lawsuits. This deal highlights a move from litigation…
Astrazeneca has brought a patent infringement case against Aurobindo Pharma over an ANDA filing for Onglyza’s generic version in the US. The dispute centres on the alleged infringement…
Google and Verizon have entered a five-year patent licensing agreement to prevent litigation over patent infringements. The deal aims to reduce exposure to patent trolls and support innovation…
The University of North Carolina reported a remarkable rise in technology licensing revenue, supported by successful biotechnology start-ups and targeted partnerships. UNC’s ongoing reinvestment of licensing earnings aims…
Dr. Kalyan Kankanala’s NLSIU presentations provide a structured overview of patent law in India and the core patentability requirements. The content includes case law analysis and practical examples,…